E S Oh, S K Hong, G I Kang
Index: Xenobiotica 22(3) , 377-84, (1992)
Full Text: HTML
1. To obtain further evidence for the metabolic formation of methamphetamine from famprofazone in man, concentrations of methamphetamine in plasma, as well as in urine, were measured by g.l.c. In addition, intact famprofazone and famprofazone N-oxide were analysed in the urine. 2. Methamphetamine appeared in plasma 1 h after a single 100 mg dose of the drug to two male subjects, and the concentration maintained between 24 and 44 ng/ml over 2-12 h, declining to 10 ng/ml and an undetectable level respectively after 24 h. 3. Total urinary excretion of methamphetamine over 72 h was 1.9 mg for a 25 mg dose and 2.2 mg for a 50 mg dose. After a 100 mg dose, 4.6 mg of methamphetamine was excreted over 36 h. Neither intact famprofazone nor famprofazone N-oxide were detected when the urine samples after the 100 mg dose were examined. 4. The results provide further evidence that methamphetamine is a bona fide human metabolite of famprofazone and suggest that at least 20% dose may be broken down via the pathways leading to the formation of methamphetamine. This could have significant clinical implications as the result of pharmacological activity of this metabolite.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Famprofazone
CAS:22881-35-2 |
C24H31N3O |
Illegal or legitimate use? Precursor compounds to amphetamin...
2000-02-01 [Drug Metab. Rev. 32(1) , 15-44, (2000)] |
Detection and identification of famprofazone and its metabol...
1994-11-18 [J. Chromatogr. B, Biomed. Appl. 661(2) , 255-61, (1994)] |
Urinary methamphetamine concentration following famprofazone...
1994-09-01 [J. Anal. Toxicol. 18(5) , 265-8, (1994)] |
Enantiomeric composition of amphetamine and methamphetamine ...
1996-07-12 [Forensic Sci. Int. 80(3) , 189-99, (1996)] |
Precursor medications as a source of methamphetamine and/or ...
2002-05-01 [J. Occup. Environ. Med. 44(5) , 435-50, (2002)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved